ArticleJournal of comparative effectiveness research2025
Cost-effectiveness of PD-L1 testing to guide immunotherapy for patients with advanced non-small-cell lung cancer in China.
Fei Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.